CPT2 and very long chain acyl-CoA dehydrogenase deficiency: There are also consistent data showing that genetic mtFAO defects, including CPT2 [86] and the VLCAD deficiency [87], can be corrected in fibroblasts from affected patients after treatment with bezafibrate.